Search Results

Kisspeptin/Gpr54-Independent Gonadotrophin-Releasing Hormone Activity in Kiss1 and Gpr54 Mutant Mice

Authors: Chan, Y. M.; Broder-Fingert, S.; Wong, K. M.; Seminara, S. B.

Source: Journal of Neuroendocrinology, Volume 21, Number 12, December 2009 , pp. 1015-1023(9)

Publisher: Blackwell Publishing

Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer

Authors: Kirby, Roger S.; Fitzpatrick, John M.; Clarke, Noel

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1580-1584(5)

Publisher: Blackwell Publishing

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

Authors: Isik, A.Z.; Caglar, G.S.; Sozen, E.; Akarsu, C.; Tuncay, G.; Ozbıcer, T.; Vicdan, K.

Source: Reproductive BioMedicine Online, Volume 19, Number 4, October 2009 , pp. 472-477(6)

Publisher: Reproductive Healthcare Ltd

Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols

Authors: Ozmen, Batuhan; Sönmezer, Murat; Atabekoglu, Cem Somer; Olmus, Hülya

Source: Reproductive BioMedicine Online, Volume 19, Number 4, October 2009 , pp. 478-485(8)

Publisher: Reproductive Healthcare Ltd

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study

Authors: Melo, M.; Busso, C.E.; Bellver, J.; Alama, P.; Garrido, N.; Meseguer, M.; Pellicer, A.; Remohí, J.

Source: Reproductive BioMedicine Online, Volume 19, Number 4, October 2009 , pp. 486-492(7)

Publisher: Reproductive Healthcare Ltd

Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders

Authors: Sönmezer, M.; Özmen, B.; Çil, A.P.; Özkavukçu, S.; Taşçı, T.; Olmuş, H.; Atabekoğlu, C.S.

Source: Reproductive BioMedicine Online, Volume 19, Number 4, October 2009 , pp. 508-513(6)

Publisher: Reproductive Healthcare Ltd

Costs and outcomes associated with IVF using recombinant FSH

Authors: Ledger, W.; Wiebinga, C.; Anderson, P.; Irwin, D.; Holman, A.; Lloyd, A.

Source: Reproductive BioMedicine Online, Volume 19, Number 3, September 2009 , pp. 337-342(6)

Publisher: Reproductive Healthcare Ltd

Degarelix

Authors: Frampton, James E.; Lyseng-Williamson, Katherine A.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1967-1976(10)

Publisher: Adis International

GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use

Authors: Martinez-Salazar, J.; Cerrillo, M.; Quea, G.; Pacheco, A.; Garcia-Velasco, J.A.

Source: Reproductive BioMedicine Online, Volume 19, Number 2, August 2009 , pp. 156-161(6)

Publisher: Reproductive Healthcare Ltd

Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer

Authors: Depalo, Raffaella; Lorusso, Filomenamila; Palmisano, Marcella; Bassi, Emma; Totaro, Ilaria; Vacca, Margherita; Trerotoli, Paolo; Masciandaro, Paola; Selvaggi, Luigi

Source: Gynecological Endocrinology, Volume 25, Number 5, May 2009 , pp. 328-334(7)

Publisher: Informa Healthcare

Prevention of OHSS

Author: Aboulghar, Mohamed

Source: Reproductive BioMedicine Online, Volume 19, Number 1, July 2009 , pp. 33-42(10)

Publisher: Reproductive Healthcare Ltd

Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation

Authors: Kol, Shahar; Dor, Jehoshua

Source: Reproductive BioMedicine Online, Volume 19, Number 1, July 2009 , pp. 59-60(2)

Publisher: Reproductive Healthcare Ltd

Comparison of Two Doses of the GnRH Antagonist, Acyline, for Pregnancy Termination in Bitches

Authors: Valiente, C; Corrada, Y; de la Sota, PE; Blanco, PG; Arias, D; Gobello, C

Source: Reproduction in Domestic Animals, Volume 44, Supplement 2, July 2009 , pp. 156-159(4)

Publisher: Blackwell Publishing

Luteal phase rescue in high-risk OHSS patientsby GnRHa triggering in combination with low-dose HCG: a pilot study

Author: Humaidan, P.

Source: Reproductive BioMedicine Online, Volume 18, Number 5, May 2009 , pp. 630-634(5)

Publisher: Reproductive Healthcare Ltd

Degarelix for prostate cancer

Authors: Doehn, Christian; Sommerauer, Martin; Jocham, Dieter

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 6, June 2009 , pp. 851-860(10)

Publisher: Informa Healthcare

The effects of luteinizing hormone ablation/replacement versus steroid ablation/replacement on gene expression in the primate corpus luteum

Authors: Bishop, Cecily V.; Hennebold, Jon D.; Stouffer, Richard L.

Source: Molecular Human Reproduction, Volume 15, Number 3, 23 March 2009 , pp. 181-193(13)

Publisher: Oxford University Press

Kisspeptin-54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms

Authors: Thompson, EL; Amber, V; Stamp, GWH; Patterson, M; Curtis, AE; Cooke, JH; Appleby, GF; Dhillo, WS; Ghatei, MA; Bloom, SR; Murphy, KG

Source: British Journal of Pharmacology, Volume 156, Number 4, February 2009 , pp. 609-625(17)

Publisher: Blackwell Publishing

Neuroendocrine Regulation of Thyroid-stimulating Hormone Secretion in Amphibians

Authors: Okada, Reiko; Kobayashi, Tetsuya; Yamamoto, Kazutoshi; Nakakura, Takashi; Tanaka, Shigeyasu; Vaudry, Hubert; Kikuyama, Sakae

Source: Annals of the New York Academy of Sciences, Volume 1163, Number 1, April 2009 , pp. 262-270(9)

Publisher: Blackwell Publishing

Effect of Suppression of FSH with a GnRH Antagonist (Acyline) Before and During Follicle Deviation in the Mare

Authors: Checura, CM; Beg, MA; Gastal, EL; Gastal, MO; Wiltbank, MC; Parrish, JJ; Ginther, OJ

Source: Reproduction in Domestic Animals, Volume 44, Number 3, June 2009 , pp. 504-511(8)

Publisher: Blackwell Publishing

Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer

Author: Anderson, John

Source: Future Oncology, Volume 5, Number 4, May 2009 , pp. 433-443(11)

Publisher: Future Medicine